We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+26.7%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.63B
AUM Growth
-$51.2M
Cap. Flow
-$796M
Cap. Flow %
-21.94%
Top 10 Hldgs %
59.45%
Holding
54
New
11
Increased
8
Reduced
25
Closed
10

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$118M
2
MAR icon
Marriott International
MAR
+$62.7M
3
DVA icon
DaVita
DVA
+$61.5M
4
DGX icon
Quest Diagnostics
DGX
+$57.9M
5
UHS icon
Universal Health Services
UHS
+$32.4M

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$158M
2
FLEX icon
Flex
FLEX
+$98.4M
3
HOLX
Hologic
HOLX
+$96.9M
4
FMC icon
FMC
FMC
+$73.4M
5
HCA icon
HCA Healthcare
HCA
+$68.1M

Sector Composition

Rank Sector Weight
1 Healthcare 70.3%
2 Technology 9.78%
3 Consumer Discretionary 6.74%
4 Materials 5.97%
5 Communication Services 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
26
Brookdale Senior Living
BKD
$3.45B
$39.3M 1.08%
13,336,554
-4,297,018
-24% -$13.9M
ESI icon
27
Element Solutions
ESI
$9.34B
$34.7M 0.96%
3,193,768
-853,565
-21% -$8.57M
UNH icon
28
UnitedHealth
UNH
$375B
$32.7M 0.9%
110,866
-170,839
-61% -$49M
ENDP
29
DELISTED
Endo International plc
ENDP
$32.4M 0.89%
9,446,971
-234,627
-2% -$899K
TMO icon
30
Thermo Fisher Scientific
TMO
$214B
$29.6M 0.81%
+81,555
New +$27.3M
EBAY icon
31
eBay
EBAY
$49.4B
$29.1M 0.8%
554,162
-281,934
-34% -$11.9M
MIK
32
DELISTED
Michaels Stores, Inc
MIK
$24.8M 0.68%
3,500,850
+918,473
+36% +$3.6M
EXPE icon
33
Expedia Group
EXPE
$38.4B
$21M 0.58%
+255,049
New +$18.5M
MYGN icon
34
Myriad Genetics
MYGN
$301M
$20.5M 0.57%
1,810,727
+271,196
+18% +$3.85M
FISV
35
Fiserv Inc
FISV
$28.9B
$16.4M 0.45%
168,200
-671,008
-80% -$67.6M
LYFT icon
36
Lyft
LYFT
$6.26B
$12.8M 0.35%
+388,614
New +$12.3M
CAR icon
37
CALL
Avis
CAR
$4.9B
$11.4M 0.32%
+500,000
New +$9.17M
PACB icon
38
Pacific Biosciences
PACB
$404M
$10.9M 0.3%
3,153,150
-75,345
-2% -$257K
BHVN
39
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.8M 0.24%
+120,332
New +$6.4M
HST icon
40
Host Hotels & Resorts
HST
$17.2B
$8M 0.22%
+741,628
New +$8.52M
BAX icon
41
Baxter International
BAX
$14.1B
$6.61M 0.18%
76,738
-406,048
-84% -$35.4M
GOOGL icon
42
Alphabet (Google) Class A
GOOGL
$4.43T
$5.45M 0.15%
76,900
-633,760
-89% -$42.7M
PRAH
43
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.2M 0.06%
+22,579
New +$2.1M
EW icon
44
Edwards Lifesciences
EW
$51.2B
$233K 0.01%
3,375
-47,343
-93% -$3.36M
ABT icon
45
Abbott
ABT
$183B
– –
-46,752
Closed -$3.69M
CHRS icon
46
Coherus Oncology
CHRS
$224M
– –
-426,738
Closed -$6.92M
CNC icon
47
Centene
CNC
$33.1B
– –
-941,457
Closed -$55.9M
FLEX icon
48
Flex
FLEX
$45B
– –
-15,584,755
Closed -$98.4M
GPN icon
49
Global Payments
GPN
$23.9B
– –
-254,865
Closed -$36.8M
ISRG icon
50
Intuitive Surgical
ISRG
$133B
– –
-44,337
Closed -$7.32M
1
2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Glenview Capital Management held 54 positions worth $3.63B, down 1.4% from $3.68B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Glenview Capital Management withdrew a net $796M in Q2 2020, closing 10 positions and reducing 25 holdings. Its most notable exit was Flex, an estimated $98.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 69% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Glenview Capital Management opened a new position in Labcorp worth $122M.

  • Glenview Capital Management's largest Q2 2020 buy was Labcorp: 854,427 shares worth $122M.
  • Glenview Capital Management added most to Universal Health Services in Q2 2020, an estimated $32.4M increase.
  • Glenview Capital Management's biggest Q2 2020 reduction was IQVIA, cutting an estimated $158M.
  • Glenview Capital Management fully exited Flex in Q2 2020, selling an estimated $98.4M.
  • Glenview Capital Management's ten largest holdings make up 59% of its $3.63B portfolio in Q2 2020.
  • Glenview Capital Management opened 11 new positions and closed 10 in Q2 2020.
  • Glenview Capital Management's portfolio value fell 1.4% quarter-over-quarter to $3.63B.

Based on Glenview Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.